A major clinical trial involving nearly 5,800 adults has challenged conventional approaches to deciding which patients should receive statins, with researchers finding that heart scans measuring calcium buildup in the arteries produced the same observed rate of major cardiovascular events as traditional risk assessments. Notably, the scan-based strategy recommended statin therapy to far fewer patients than standard risk scoring methods, suggesting that widespread prescribing may not be necessary to achieve comparable outcomes. The findings, published in a leading medical journal, add fresh evidence to the long-running debate over how best to identify individuals at genuine risk of heart attack and stroke.
Perhaps the most striking result concerned patient behavior: participants advised to take statins on the basis of their coronary calcium scans were nearly three times as likely to adhere to their medication compared with those following traditional risk assessments. Researchers say the visual evidence of calcium buildup may make the threat of heart disease more tangible, improving persistence with treatment. The trial raises intriguing questions about how doctors should balance population-wide risk models against individualized imaging, and whether targeted testing could improve both treatment decisions and patient commitment while reducing unnecessary prescriptions. Further analyses are expected as clinicians weigh the implications for routine practice.
Independent reporting synthesized from primary wires and global correspondents.